Practice Gaps in Pediatric Atopic Dermatitis Reveal Need for Uniform, Effective Care
Treatment varies greatly for pediatric patients with atopic dermatitis as drugs with known risks continue to be popular and beneficial agents are rarely prescribed.
Atopic Dermatitis
Long-Term Dupilumab Therapy Shows Sustained Improvements in Atopic Dermatitis Symptoms
The safety and efficacy profile from this study supports the role of dupilumab as continuous long-term treatment for patients with moderate to severe atopic dermatitis.
Atopic Dermatitis Associated With Frequent Cutaneous Comorbidity
Cutaneous comorbidity is frequent in those with atopic dermatitis, suggesting the need for comprehensive, dermatologically guided diagnostics.
Apple Cider Vinegar Soaks Do Not Improve Skin Barrier Integrity in Atopic Dermatitis
Dilute apple cider vinegar soaks had no significant effect on skin barrier integrity but did cause skin irritation in the majority of participants, this study finds.
Dupilumab Ocular Surface Disease More Common in Atopic Dermatitis
Data suggest that individuals with atopic dermatitis may have unique ocular properties that are responsible for the development of ocular surface disease.
ETFAD Releases Treatment Recommendations for Atopic Dermatitis in Pregnancy
Treatment of atopic dermatitis should generally follow a “safety first” approach with effective treatment options rather than avoiding nearly all possible treatment modalities.
Improved Patient-Reported Outcomes With Dupilumab for Atopic Dermatitis
Dupilumab may effect more than just symptoms of atopic dermatitis as patients report improvement in anxiety, depression, and HRQoL.
Picture-Based Tool Reliably Assesses Affected BSA in Psoriasis
Picture Tool Is Fast, Reliable for Estimating Affected Psoriasis and Atopic Dermatitis Body Surface Area and Treatment Dosage
Crisaborole Ointment 2% Evaluated in Younger Patients With Atopic Dermatitis
Top-line results from the CrisADe CARE 1 phase 4 trial showed that crisaborole ointment 2% (Eucrisa; Pfizer) was well-tolerated in children aged 3 months to less than 24 months with mild to moderate atopic dermatitis.
Severe Pruritus Predicts Worse QoL in Mild to Moderate Atopic Dermatitis
Investigators evaluated the association between pruritus and quality of life, using data from 2 phase 3 studies.
Next post in Practice Management
